Endometrial cancer is a type of cancer in the lining of the uterus (also known as the endometrium). It is the most common type of gynecologic cancer in women. There are many treatments for endometrial ...

Jemperli (dostarlimab-gxly) is a brand-name drug that’s prescribed for certain types of cancers in adults. Jemperli comes as a liquid for intravenous (IV) infusion that’s given by a healthcare ...

Jemperli (dostarlimab-gxly) is a brand-name injection that’s prescribed for certain types of cancers in adults. As with other drugs, Jemperli can cause side effects, such as diarrhea, anemia, and skin ...

Credit: GSK Dostarlimab plus carboplatin-paclitaxel reduced the risk of disease progression by 71% vs chemotherapy alone. The Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) in ...

Patients with advanced or recurrent endometrial cancer derived a survival benefit from Jemperli plus chemotherapy. Treatment with the immunotherapy agent, Jemperli (dostarlimab), plus chemotherapy ...

Jemperli (dostarlimab-gxly) is a prescription drug that’s used to treat certain types of cancer. The drug comes as a liquid solution for intravenous infusion by a healthcare professional. It’s usually ...

Jemperli (dostarlimab-gxly) is a prescription drug used to treat certain cancers. Jemperli can cause side effects that range from mild to serious. Examples include anemia and infusion-related ...